Network Bio
2 known investors
Network Bio activates biobanks through securitization and capital infusion, providing research-grade data assets and operational infrastructure for precision medicine and biomedical research.
BiotechData & InfrastructureDigital Health
Investors · 2
Competitors · 8
by search overlapbio11 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Access BIO10 shared keywordsAccess Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
Bridgebio10 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Engage Bio7 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Character Bio6 shared keywordsCharacter Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma. It uses this data platform to discover and develop targeted therapies in ophthalmology for patients with these conditions.
Nuvation Bio6 shared keywordsNuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.
Senti Biosciences6 shared keywordsSenti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells. The company is a clinical-stage biotech firm leveraging proprietary platform technology across multiple cell types and modalities.
Transition Bio6 shared keywordsTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Companies competing with Network Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Network Bio do?
- Network Bio activates biobanks through securitization and capital infusion, providing research-grade data assets and operational infrastructure for precision medicine and biomedical research.
- Who are Network Bio's investors?
- Network Bio's investors include Artis Ventures, Breyer Capital.